167 related articles for article (PubMed ID: 18384679)
1. Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores.
Moore RA; Moore OA; Derry S; McQuay HJ
Arthritis Res Ther; 2008; 10(2):R39. PubMed ID: 18384679
[TBL] [Abstract][Full Text] [Related]
2. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
Moore RA; Moore OA; Derry S; Peloso PM; Gammaitoni AR; Wang H
Ann Rheum Dis; 2010 Feb; 69(2):374-9. PubMed ID: 19364730
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis.
Peloso PM; Gammaitoni A; Smugar SS; Wang H; Moore AR
BMC Musculoskelet Disord; 2011 Jul; 12():165. PubMed ID: 21767407
[TBL] [Abstract][Full Text] [Related]
4. Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
Curtis SP; Bockow B; Fisher C; Olaleye J; Compton A; Ko AT; Reicin AS
BMC Musculoskelet Disord; 2005 Dec; 6():58. PubMed ID: 16321158
[TBL] [Abstract][Full Text] [Related]
5. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
Gottesdiener K; Schnitzer T; Fisher C; Bockow B; Markenson J; Ko A; DeTora L; Curtis S; Geissler L; Gertz BJ;
Rheumatology (Oxford); 2002 Sep; 41(9):1052-61. PubMed ID: 12209041
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.
Puopolo A; Boice JA; Fidelholtz JL; Littlejohn TW; Miranda P; Berrocal A; Ko A; Cichanowitz N; Reicin AS
Osteoarthritis Cartilage; 2007 Dec; 15(12):1348-56. PubMed ID: 17631392
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.
Wiesenhutter CW; Boice JA; Ko A; Sheldon EA; Murphy FT; Wittmer BA; Aversano ML; Reicin AS;
Mayo Clin Proc; 2005 Apr; 80(4):470-9. PubMed ID: 15819283
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
Birbara CA; Puopolo AD; Munoz DR; Sheldon EA; Mangione A; Bohidar NR; Geba GP;
J Pain; 2003 Aug; 4(6):307-15. PubMed ID: 14622687
[TBL] [Abstract][Full Text] [Related]
9. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
Malmstrom K; Sapre A; Couglin H; Agrawal NG; Mazenko RS; Fricke JR
Clin Ther; 2004 May; 26(5):667-79. PubMed ID: 15220011
[TBL] [Abstract][Full Text] [Related]
10. Single dose oral etoricoxib for acute postoperative pain in adults.
Clarke R; Derry S; Moore RA
Cochrane Database Syst Rev; 2012 Apr; (4):CD004309. PubMed ID: 22513922
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
Cannon CP; Curtis SP; Bolognese JA; Laine L;
Am Heart J; 2006 Aug; 152(2):237-45. PubMed ID: 16875903
[TBL] [Abstract][Full Text] [Related]
12. Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
Bingham CO; Bird SR; Smugar SS; Xu X; Tershakovec AM
Osteoarthritis Cartilage; 2008 Nov; 16(11):1289-93. PubMed ID: 18514551
[TBL] [Abstract][Full Text] [Related]
13. Single dose oral etoricoxib for acute postoperative pain in adults.
Clarke R; Derry S; Moore RA; McQuay HJ
Cochrane Database Syst Rev; 2009 Apr; (2):CD004309. PubMed ID: 19370600
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M
Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM
BMC Musculoskelet Disord; 2016 Aug; 17():331. PubMed ID: 27502582
[TBL] [Abstract][Full Text] [Related]
16. The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain.
Malmstrom K; Ang J; Fricke JR; Shingo S; Reicin A
Curr Med Res Opin; 2005 Jan; 21(1):141-9. PubMed ID: 15881486
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports.
Moore RA; Derry S; McQuay HJ
Arthritis Res Ther; 2008; 10(3):R53. PubMed ID: 18466615
[TBL] [Abstract][Full Text] [Related]
18. Relative efficacy and tolerability of etoricoxib, celecoxib, and naproxen in the treatment of osteoarthritis : A Bayesian network meta-analysis of randomized controlled trials based on patient withdrawal.
Song GG; Seo YH; Kim JH; Choi SJ; Ji JD; Lee YH
Z Rheumatol; 2016 Jun; 75(5):508-16. PubMed ID: 26768273
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of quality of life following treatment with etoricoxib in patients with arthritis or low-back pain: an open label, uncontrolled pilot study in Mexico.
Ramos-Remus CR; Hunsche E; Mavros P; Querol J; Suarez R
Curr Med Res Opin; 2004 May; 20(5):691-8. PubMed ID: 15140335
[TBL] [Abstract][Full Text] [Related]
20. Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study.
Viscusi ER; Frenkl TL; Hartrick CT; Rawal N; Kehlet H; Papanicolaou D; Gammaitoni A; Ko AT; Morgan LM; Mehta A; Curtis SP; Peloso PM
Curr Med Res Opin; 2012 Aug; 28(8):1323-35. PubMed ID: 22738802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
